Anna Kukharenok advises public and private companies on corporate law matters. She has represented clients in domestic and cross-border mergers, acquisitions, financings, corporate restructurings, and other strategic transactions.
Anna has represented clients in a range of industries, including real estate, technology, and life sciences. Her recent representations include Astellas Pharma in its $5.9 billion acquisition of Iveric Bio and Organon & Co. in its strategic investment in Claria Medical. In addition, she has experience advising companies on corporate governance matters.
Anna also maintains an active pro bono practice, assisting nonprofits in their corporate governance matters and representing individuals seeking asylum in the United States.
Anna is author of "From Bus Bans on Religious Advertisements to Beyond: Why Religion Is More Appropriately Classified as a Viewpoint Rather Than a Subject Matter, 59 San Diego L. Rev. 531 (2022).
- University of San Diego (J.D. summa cum laude 2022; Order of the Coif); University of California, Los Angeles (B.A. in Psychology cum laude 2018)
- Extern to Judge Thomas J. Whelan (Fall 2020) and Magistrate Judge William V. Gallo (Summer 2020), U.S. District Court, Southern District of California